Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects
Pharmaceuticals · 07.11.2024 · 17 (11) · 1493
DOI: 10.3390/ph17111493 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.11.2024. Verfasst von Yanwen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Medical School, Kunming University of Science and Technology, Kunming 650500, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Special Project of Yunnan Provincial Department of Science and Technology, Kunming University of Science and Technology for Applied Basic Research, Kunming University of Science and Technology.
Themen: Schlaganfall
Abstract (Originalsprache)
Background/Objectives: Ischemic stroke is a leading cause of disability and mortality worldwide, with current therapies limited in addressing its complex pathophysiological mechanisms, such as inflammation, oxidative stress, apoptosis, and impaired autophagy. Glycyrrhizic acid (GA), a bioactive compound from licorice (Glycyrrhiza glabra L.), has demonstrated neuroprotective properties in preclinical studies. This review consolidates current evidence on GA’s pharmacological mechanisms and assesses its potential as a therapeutic agent for ischemic stroke.
Methods
This review examines findings from recent preclinical studies and reviews on GA’s neuroprotective effects, focusing on its modulation of inflammation, oxidative stress, apoptosis, and autophagy. Studies were identified from major scientific databases, including PubMed, Web of Science, and Embase, covering research from January 2000 to August 2024.
Results
GA has demonstrated significant neuroprotective effects through the modulation of key pathways, including HMGB1/TLR4/NF-κB and Keap1/Nrf2, thereby reducing neuroinflammation, oxidative stress, and apoptosis. Additionally, GA promotes autophagy and modulates immune responses, suggesting it could serve as an adjunct therapy to enhance the efficacy and safety of existing treatments, such as thrombolysis.
Conclusions
Current findings underscore GA’s potential as a multi-targeted neuroprotective agent in ischemic stroke, highlighting its anti-inflammatory, antioxidant, and anti-apoptotic properties. However, while preclinical data are promising, further clinical trials are necessary to validate GA’s therapeutic potential in humans. This review provides a comprehensive overview of GA’s mechanisms of action, proposing directions for future research to explore its role in ischemic stroke management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medicine, Medical School, Kunming University of Science and Technology, Kunming 650500, China.
- Department of Medicine, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, UPM, Serdang 43400, Malaysia.
- Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, UPM, Serdang 43400, Malaysia.
- Genetics and Regenerative Medicine Research Centre, Universiti Putra Malaysia, UPM, Serdang 43400, Malaysia.
ORCID-Profile: Yanwen Li, Thilakavathy Karuppiah, Jiaxin Liu, Zhong Sun
Förderung
- Joint Special Project of Yunnan Provincial Department of Science and Technology, Kunming University of Science and Technology for Applied Basic Research
- Kunming University of Science and Technology
Zitieren
APA
Li, Y., Wu, J., Du, F., Tang, T., Lim, J. C. W., Karuppiah, T., Liu, J., & Sun, Z. (2024). Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects. Pharmaceuticals, 17(11), 1493. https://doi.org/10.3390/ph17111493
Vancouver
Li Y, Wu J, Du F, Tang T, Lim JCW, Karuppiah T, et al. Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects. Pharmaceuticals. 2024;17(11):1493. doi:10.3390/ph17111493
BibTeX
@article{Li2024,
author = {Li, Yanwen and Wu, Juan and Du, Fang and Tang, Tao and Lim, Jonathan Chee Woei and Karuppiah, Thilakavathy and Liu, Jiaxin and Sun, Zhong},
title = {Neuroprotective Potential of Glycyrrhizic Acid in Ischemic Stroke: Mechanisms and Therapeutic Prospects},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {11},
pages = {1493},
doi = {10.3390/ph17111493}
}
EUVIMED